| | Class 2 Device Recall NextSeq" 550Dx |  |
| Date Initiated by Firm | October 28, 2025 |
| Date Posted | December 04, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0884-2026 |
| Recall Event ID |
97913 |
| Product Classification |
Reagents for molecular diagnostic test systems - Product Code PFT
|
| Product | Reagent Kits/ containing flow cells, components of NextSeq 550Dx Instrument:
NextSeq 550Dx High Output Reagent Kit v2.5 (75 cycles) IVD, REF: 20028870/NextSeq 550Dx HO FC Cart v2.5, 75 Cycles, REF: 20031098;
NextSeq 550Dx High Output Reagent Kit v2.5 (300 cycles) IVD, REF: 20028871/NextSeq 550Dx HO FC Cart v2.5, 300 Cycles, REF: 20026365;
CN NextSeq 550Dx High Output Reagent Kit v2.5 (75 cycles) IVD, REF: 20064341/CN NEXTSEQ 550Dx HO FLOW CELL V2.5, REF: 20062316;
CN NextSeq 550Dx High Output Reagent Kit v2.5 (300 cycles) IVD, REF: 20064344/CN NEXTSEQ 550Dx HO FLOW CELL V2.5, REF: 20062316;
CN NextSeq 550Dx Mid Output Reagent Kit v2.5 (150 cycles) IVD, 20064345/CN NEXTSEQ 550Dx MO FLOW CELL V2.5, REF: 20062530;
CN NextSeq 550Dx Mid Output Reagent Kit v2.5 (300 cycles) IVD, 20064346/CN NEXTSEQ 550Dx MO FLOW CELL V2.5, REF: 20062530;
/FLOWCELL, FIT FLUIDICS TESTING, REF: 15050205 |
| Code Information |
NextSeq 550Dx UDI-DI: 00816270020125.
Kit REF/Flow Cell REF/UDI-DI(Lot):
20028870/20031098/00816270020132(A184824-3, A185016-3, A183951-3, A182816-3, A183339-3, A182533-3, A183950-3, A184531-3, A182413-3, A184058-3, A183613-3, A183211-3, A183612-3, A183826-3, A182302-3, A183449-3, A182298-3, A182532-3, A182299-3, A183830-3, A183118-3, A182301-3, A184359-3, A184727-3);
20028871/20026365/00816270020118(A182717-3, A182051-3, A179804-3, A183343-3);
20064341/20062316/006975709330014(A183402-4, A183550-4);
20064344/20062316/006975709330038(A186185-4, A183170-4, A183404-4, A183555-4, A183557-4);
20064345/20062530/006975709330045(A186074-4, A183278-4, A183405-4, A184005-4);
20064346/20062530/006975709330052(A185054-4, A183279-4, A183409-4, A183568-4, A183569-4, A183570-4, A184776-4);
15050205(20935999, 20956354) |
| FEI Number |
3003218906
|
Recalling Firm/ Manufacturer |
Illumina, Inc. 5200 Illumina Way San Diego CA 92122-4616
|
| For Additional Information Contact | Christine Douglass 971-295-9188 |
Manufacturer Reason for Recall | An instrument intended for sequencing DNA libraries with in vitro diagnostic assays is used with reagent kits including flow cells that have flow cell gaskets that have a quality issue, which may lead to flow cell leaks during runs, which could cause run failures, that may result in: No/insufficient data output, instrument fluidics clogs, toxic substance exposure to user. |
FDA Determined Cause 2 | Vendor change control |
| Action | On 10/28/2025, recall notices were emailed to customers who were asked to do the following:
Dispose of reagents per local regulations. See Instrument Reference Guide: https://support.illumina.com/downloads/nextseq-550dx-instrument-reference-guide-1000000009513.html
Illumina requests that this notice be communicated to all relevant personnel within your organization and to any external organization that has received the potentially affected reagent kits.
If you experienced a run failure in a previous run using an affected flow cell, or experience leaking issues please contact Illumina Technical Support at techsupport@illumina.com
Complete and return the verification form via email to techsupport@illumina.com |
| Quantity in Commerce | 11916 |
| Distribution | Worldwide - US Nationwide distribution in the states of PA, NJ, CA, NC, UT, IL, MD, NY, VA, WV, SD, TX, AL, SC, TN, KY, MI and the countries of DK, SA, FR, DE, IT, CN, PL, GB, TH, GR, VN, BE, ES, IL, KR, AU, CH, BG, NL, IE, TW, TR, CZ, HU, NO, FI, JP, SG, LU, AT, AE, ZA, PT, LT, SE.
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|